CORDINUS Trademark

Trademark Overview

On Tuesday, June 1, 2010, a trademark application was filed for CORDINUS with the United States Patent and Trademark Office. The USPTO has given the CORDINUS trademark a serial number of 85051641. The federal status of this trademark filing is ABANDONED - NO STATEMENT OF USE FILED as of Monday, May 19, 2014. This trademark is owned by Glaxo Group Limited. The CORDINUS trademark is filed in the Pharmaceutical Products category with the following description:

Pharmaceutical preparations and substances for the treatment of infectious diseases, blood disorders, pain, inflammation, sepsis, alopecia, obesity and cognitive disorders; Pharmaceutical preparations and substances for the treatment of viral, metabolic, endocrine, musculoskeletal, cardiovascular, cardiopulmonary, genitourinary, sexual dysfunction, oncological, hepatological, ophthalmic, respiratory, neurological, gastrointestinal, hormonal, dermatological, psychiatric and immune system related diseases and disorders; Pharmaceutical preparations and substances for the treatment of damaged skin and tissue; and for vaccines
cordinus

General Information

Serial Number85051641
Word MarkCORDINUS
Filing DateTuesday, June 1, 2010
Status606 - ABANDONED - NO STATEMENT OF USE FILED
Status DateMonday, May 19, 2014
Registration Number0000000
Registration DateNOT AVAILABLE
Mark Drawing4000 - Illustration: Drawing with word(s) / letter(s) / number(s) in Block form
Published for Opposition DateTuesday, October 12, 2010

Trademark Statements

Goods and ServicesPharmaceutical preparations and substances for the treatment of infectious diseases, blood disorders, pain, inflammation, sepsis, alopecia, obesity and cognitive disorders; Pharmaceutical preparations and substances for the treatment of viral, metabolic, endocrine, musculoskeletal, cardiovascular, cardiopulmonary, genitourinary, sexual dysfunction, oncological, hepatological, ophthalmic, respiratory, neurological, gastrointestinal, hormonal, dermatological, psychiatric and immune system related diseases and disorders; Pharmaceutical preparations and substances for the treatment of damaged skin and tissue; and for vaccines

Classification Information

International Class005 - Pharmaceutical and veterinary preparations; sanitary preparations for medical purposes; dietetic substances adapted for medical use, food for babies; plasters, materials for dressings; material for stopping teeth, dental wax; disinfectants; preparations for destroying vermin; fungicides, herbicides.
US Class Codes006, 018, 044, 046, 051, 052
Class Status Code6 - Active
Class Status DateFriday, June 4, 2010
Primary Code005
First Use Anywhere DateNOT AVAILABLE
First Use In Commerce DateNOT AVAILABLE

Trademark Owner History

Party NameGlaxo Group Limited
Party Type20 - Owner at Publication
Legal Entity Type03 - Corporation
AddressBrentford, Middlesex TW89GS
GB
Party NameGlaxo Group Limited
Party Type10 - Original Applicant
Legal Entity Type03 - Corporation
AddressGreenford, Middlesex UB60NN
GB

Trademark Events

Event DateEvent Description
Monday, May 19, 2014ABANDONMENT NOTICE MAILED - NO USE STATEMENT FILED
Monday, May 19, 2014ABANDONMENT - NO USE STATEMENT FILED
Saturday, September 28, 2013NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Friday, September 27, 2013EXTENSION 5 GRANTED
Wednesday, September 25, 2013EXTENSION 5 FILED
Wednesday, September 25, 2013TEAS EXTENSION RECEIVED
Saturday, April 6, 2013NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Friday, April 5, 2013EXTENSION 4 GRANTED
Wednesday, April 3, 2013EXTENSION 4 FILED
Wednesday, April 3, 2013TEAS EXTENSION RECEIVED
Wednesday, March 20, 2013APPLICANT/CORRESPONDENCE CHANGES (NON-RESPONSIVE) ENTERED
Wednesday, March 20, 2013TEAS CHANGE OF OWNER ADDRESS RECEIVED
Friday, March 15, 2013ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED
Friday, March 15, 2013TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED
Tuesday, September 25, 2012NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Monday, September 24, 2012EXTENSION 3 GRANTED
Friday, September 21, 2012EXTENSION 3 FILED
Friday, September 21, 2012TEAS EXTENSION RECEIVED
Friday, April 27, 2012NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Thursday, April 26, 2012EXTENSION 2 GRANTED
Monday, March 26, 2012EXTENSION 2 FILED
Wednesday, April 25, 2012CASE ASSIGNED TO INTENT TO USE PARALEGAL
Monday, March 26, 2012TEAS EXTENSION RECEIVED
Wednesday, October 5, 2011NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Monday, October 3, 2011EXTENSION 1 GRANTED
Monday, October 3, 2011EXTENSION 1 FILED
Monday, October 3, 2011TEAS EXTENSION RECEIVED
Tuesday, April 12, 2011NOA E-MAILED - SOU REQUIRED FROM APPLICANT
Friday, February 25, 2011EXTENSION OF TIME TO OPPOSE PROCESS - TERMINATED
Wednesday, November 10, 2010EXTENSION OF TIME TO OPPOSE RECEIVED
Tuesday, October 12, 2010OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
Tuesday, October 12, 2010PUBLISHED FOR OPPOSITION
Thursday, September 9, 2010LAW OFFICE PUBLICATION REVIEW COMPLETED
Thursday, September 9, 2010ASSIGNED TO LIE
Thursday, August 26, 2010APPROVED FOR PUB - PRINCIPAL REGISTER
Thursday, August 26, 2010ASSIGNED TO EXAMINER
Saturday, June 5, 2010NOTICE OF PSEUDO MARK MAILED
Friday, June 4, 2010NEW APPLICATION OFFICE SUPPLIED DATA ENTERED IN TRAM
Friday, June 4, 2010NEW APPLICATION ENTERED IN TRAM

Related Keywords

cordinus pharmaceutical treatment substances disorders preparations diseases hormonal neurological gastrointestinal ophthalmic